News

The COVID-19 pandemic has profoundly impacted on our daily lives, including our behaviour as consumers. Just as we have seen online shopping for other goods increase during lockdowns, will we see a...

Revolutionary changes, both in the extent and nature of the drugs problem, and in the world in which we live, have called for constant reflection, innovation and agility to keep pace with...

The European Drugs Summer School (EDSS) will switch to remote teaching this year in an effort to help curb the spread of COVID-19 and reduce pressure on health services. The 2020 EDSS...

Crucial information on the impact of COVID-19 on people who use drugs, and on the services that support them, will be collected via a special round of the European Web Survey on...

Drugs have long been a cross-border phenomenon. As drug problems in Europe are increasingly linked to, and influenced by, global developments, it is crucial that our analysis of trends and developments be...

What specific risks are people who use drugs (PWUD) likely to face during the COVID-19 pandemic? What services will they need? How will professionals working with this group need to adapt on...

A large earthquake rocked Croatian capital Zagreb on 22 March, increasing the strain on the country’s emergency services, which are already challenged by the COVID-19 pandemic. The EMCDDA offers its solidarity to...

EMCDDA staff members will be switching to teleworking today following a decision by its Director Alexis Goosdeel (1). The decision comes as the COVID-19 pandemic continues to intensify and as the EU...

The latest findings from the largest European project in the emerging science of wastewater analysis are presented today by the Europe-wide SCORE group, in association with the EU drugs agency (EMCDDA) (1)...

This content was published in the third EU4MD update released on 07.02.2020. This update also presents a section on partnerships and related activities, upcoming events, and a research corner. Focus on new...

Professionals, academics and experts from the Western Balkan region will have an opportunity to participate in the European Drugs Summer School (EDSS) this year, thanks to three bursaries being offered through the...

This year, the EMCDDA celebrates 25 years of monitoring the drug situation in Europe. In the quarter of a century since the agency embarked on its first work programme in 1995, we...

EMCDDA Director Alexis Goosdeel was at the European Parliament today, where he presented the findings of the EMCDDA–Europol EU Drug Markets Report 2019 (EDMR 2019) to the Committee on Civil Liberties, Justice...

EMCDDA Director Alexis Goosdeel is in Washington today where he will meet Ambassador Adam Namm, Executive Secretary of the Inter-American Drug Abuse Control Commission (CICAD). The purpose of the visit is to...

From 16 December 2019, edible cannabis products are permitted to be sold in Canada. These must comply with new regulations for edible, inhalable and topical products, designed to reduce the risk of...

Pharmacotherapies for the treatment of cocaine use disorders There are signs that increased cocaine availability in Europe is resulting in growing health costs. Since 2014, the number of new clients entering treatment...

Professionals, academics or experts from European Neighbourhood Policy (ENP) countries will have an opportunity to participate in the European Drugs Summer School (EDSS) in 2020, thanks to five bursaries being offered through...

Professionals, academics and experts from European Neighbourhood Policy (ENP) countries will have the opportunity to participate in the 2020 National Institute on Drug Abuse International Forum, thanks to five bursaries being offered...

On 13 December, the EMCDDA Management Board appointed 15 high-level scientists to serve on the agency’s Scientific Committee for the period 2020–22. The selection followed a call for expressions of interest in...

On 5 and 6 December 2019, 150 participants took part in the final conference of Efus’ SOLIDIFY project, held in Lisbon, Portugal. Co-hosted with the European Monitoring Centre for Drugs and Drug...